APUS

AMEX Apimeds Pharmaceuticals US, Inc.
Sep 30, 2026 · 4:37 PM ET LAST TRADE Market Closed

$4.81 ↓ -0.19 (-3.80%) Trading Down from the previous close of $5.00, $0.44 below the day’s high of $5.25

YTD change
-83.97%
vs 20-day SMA
+65.51%
vs 200-day SMA
N/A

Price ranges

Previous day
$4.63 $6.17
open $6.17 close $5.02
-$1.15 (-18.64%)
Today
$4.72 $5.25
open $5.04 now $4.81
-$0.23 (-4.56%)
Past week
$1.74 $9.14
from $1.85 now $4.81
+$2.96 (+160.00%)
Past month
$1.51 $9.14
from $3.88 now $4.81
+$0.93 (+23.97%)
This year
$0.61 $30.00
from $30.00 now $4.81
-$25.19 (-83.97%)

Price & Performance

+3.27 (+186.86%) / 6M

$0.0480$2.89$5.74$8.59Mar 30Jul 15Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 91.9% away from all-time highs of $59.70
  • APUS is down 84% since the beginning of the year
  • APUS is down 84% over the past 12 months
  • APUS is up 24% over the past 1 month
  • 2% of all APUS investors are betting against APUS
  • Number of investors short APUS has gone down 61% versus last month

APUS reads not so good: short interest is falling month over month, the 12-month move is +182.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-11.7737
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $14.9M
Beta 0.06

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$8.3M
Debt$14.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeAMEX
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $7.3M

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,184.63 -0.01%
JNJ Johnson & Johnson $267.57 -1.61%
ABBV AbbVie, Inc. $263.29 -1.12%
MRK Merck & Co., Inc. $149.28 +0.40%
RHHVF Roche Holding Ltd $431.56 -2.94%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.